Quince Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Quince Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q1 2019 to Q2 2024.
  • Quince Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending June 30, 2024 was $127K.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $127K Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $130K Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $88K +$88K Dec 31, 2023 10-K 2024-04-01
Q4 2022 $0 -$422K -100% Dec 31, 2022 10-K 2023-03-15
Q1 2022 $70K Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $422K +$352K +503% Dec 31, 2021 10-K 2022-03-01
Q4 2020 $70K Dec 31, 2020 10-K 2021-03-01
Q3 2020 $70K Sep 30, 2020 10-Q 2020-11-12
Q1 2020 $24K -$190K -88.8% Mar 31, 2020 10-Q 2020-05-12
Q1 2019 $214K Mar 31, 2019 10-Q 2019-06-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.